On July 1, the U.S. Drug Enforcement Administration (DEA) filed two Notices of Intent to temporarily place highly concentrated and synthetic kratom-related substances into Schedule I of the Controlled Substances Act. Additionally, the Office of the Assistant Secretary for Health (OASH) issued a Request for Information seeking public comment on scientific data on the proposed threshold level.
